Bronchoprotective Effects of Leukotriene Receptor Antagonists in Asthma

Chest - United States
doi 10.1378/chest.122.1.146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Leukotriene Receptor Antagonists Pranlukast and Montelukast for Treating Asthma

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

Leukotriene Receptor Antagonists and Biosynthesis Inhibitors: Potential Breakthrough in Asthma Therapy

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1995English

Churg-Strauss Vasculitis Syndrome and Leukotriene Receptor Antagonists

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Inhaled Glucocorticoids Versus Leukotriene Receptor Antagonists as Single Agent Asthma Treatment: Systematic Review of Current Evidence

BMJ
2003English

The Effects of Low Dose Leukotriene Receptor Antagonist Therapy on Airway Remodeling and Cysteinyl Leukotriene Expression in a Mouse Asthma Model

Experimental & Molecular Medicine
2006English

Role of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2005English

Leukotriene Receptor Antagonists as Potential Steroid Sparing Agents in a Patient With Serosal Eosinophilic Gastroenteritis

Gut
Gastroenterology
2006English

Leukotriene Antagonists and Churg-Strauss Syndrome: The Smoking Gun

Thorax
PulmonaryRespiratory Medicine
1999English

Leukotriene B4 Levels in Sputum From Asthma Patients

ERJ Open Research
PulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy